USE OF DNA ISOLATED FROM BONE MARROW SAMPLES IN PARAFFIN BLOCKS FROM PATIENTS WITH MPN TO ANALYZE SOMATIC MUTATIONS

by Dmitry Vladimirovich Kurochkin, Anastasia Aleksandrovna Karnyushka, Tatyana Yuryevna Petrichenko, Tatiana Nikolaevna Subbotina, Tatyana Andreevna Garkusha, Anna Sergeevna Khazieva, Vladimir Alekseevich Khorzhevsky
Published 2019-06-01

Calreticulin Blockade Attenuates Murine Acute Lung Injury by Inducing Polarization of M2 Subtype Macrophages

by Zhilong Jiang, Zhihong Chen, Lu Hu, Lin Qiu, Lei Zhu
Published 2020-01-01

CALR-TLR4 Complex Inhibits Non-Small Cell Lung Cancer Progression by Regulating the Migration and Maturation of Dendritic Cells

by Ruo Chen, Min Huang, Xu Yang, Xiao-Hong Chen, Ming-Yan Shi, Zhuo-Fan Li, Zhi-Nan Chen, Ke Wang
Published 2021-10-01

Comparison of molecular genetic methods of detection of mutations in the CALR gene in myeloproliferative disorders

by L. A. Kesaeva, A. Yu. Bulanov, Yu. P. Finashutina, V. V. Tikhonova, O. N. Solopova, E. N. Misyurina, N. N. Kasatkina, N. A. Lyzhko, V. A. Misyurin, A. A. Turba, A. A. Solodovnik, I. N. Soldatova, A. V. Misyurin
Published 2019-07-01

Remodeling the Bone Marrow Microenvironment – A Proposal for Targeting Pro-inflammatory Contributors in MPN

by Jonas Samuel Jutzi, Ann Mullally, Ann Mullally, Ann Mullally
Published 2020-08-01

Novel therapeutics in myeloproliferative neoplasms

by Sangeetha Venugopal, John Mascarenhas
Published 2020-12-01

Application of heteroduplex analysis for CALR mutation screening detection in patients with Ph-myeloproliferative neoplasms

by T. N. Subbotina, D. V. Kurochkin, I. E. Maslyukova, A. S. Khazieva, E. V. Vasiliev, M. A. Mikhalev, E. A. Dunaeva, K. O. Mironov
Published 2021-06-01

MPN: The Molecular Drivers of Disease Initiation, Progression and Transformation and their Effect on Treatment

by Julian Grabek, Jasmin Straube, Megan Bywater, Steven W. Lane
Published 2020-08-01

Isolation of T cell receptors targeting recurrent neoantigens in hematological malignancies

by Vanessa M. Tubb, Deborah S. Schrikkema, Nathan P. Croft, Anthony W. Purcell, Carsten Linnemann, Manon R. Freriks, Frederick Chen, Heather M. Long, Steven P. Lee, Gavin M. Bendle
Published 2018-07-01

Myeloproliferative neoplasm-driving Calr frameshift promotes the development of pulmonary hypertension in mice

by Keiji Minakawa, Tetsuro Yokokawa, Koki Ueda, Osamu Nakajima, Tomofumi Misaka, Yusuke Kimishima, Kento Wada, Yusuke Tomita, Saori Miura, Yuka Sato, Kosaku Mimura, Koichi Sugimoto, Kazuhiko Nakazato, Kenneth E. Nollet, Kazuei Ogawa, Takayuki Ikezoe, Yuko Hashimoto, Yasuchika Takeishi, Kazuhiko Ikeda
Published 2021-03-01

A Broad Overview of Signaling in <i>Ph</i>-Negative Classic Myeloproliferative Neoplasms

by Ana Guijarro-Hernández, José Luis Vizmanos
Published 2021-02-01

Transcriptional regulation of the virulence genes and the biofilm formation associated operons in Vibrio parahaemolyticus

by Yiquan Zhang, Yue Qiu, Xingfan Xue, Miaomiao Zhang, Junfang Sun, Xue Li, Lingfei Hu, Zhe Yin, Wenhui Yang, Renfei Lu, Dongsheng Zhou
Published 2021-03-01

Molecular Genetic Markers and Clinical Characteristics of Essential Thrombocythemia

by AA Zhernyakova, IS Martynkevich, VA Shuvaev, LB Polushkina, MS Fominykh, VYu Udal’eva, II Zotova, DI Shikhbabaeva, MN Zenina, NA Potikhonova, SV Voloshin, SS Bessmel’tsev, AV Chechetkin, KM Abdulkadyrov
Published 2017-07-01

Rapid, low cost and sensitive detection of Calreticulin mutations by a PCR based amplicon length differentiation assay for diagnosis of myeloproliferative neoplasms

by Ngo Tat Trung, Dao Thanh Quyen, Nghiem Xuan Hoan, Dao Phuong Giang, Tran Thi Huyen Trang, Thirumalaisamy P. Velavan, Mai Hong Bang, Le Huu Song
Published 2019-06-01

Novel dilated cardiomyopathy associated to Calreticulin and Myo7A gene mutation in Usher syndrome

by Andrea Frustaci, Alessandro De Luca, Nicola Galea, Romina Verardo, Valentina Guida, Rosalba Carrozzo, Cristina Chimenti, Emanuela Frustaci, Luigi Sansone, Matteo Antonio Russo
Published 2021-06-01

Clinical features of essential thrombocythemia and primary myelofibrosis, depending on the molecular characteristics of disease

by A L Melikyan, I N Subortseva, A B Sudarikov, A M Kovrigina, E A Gilyazitdinova, T I Kolosheinova, A O Abdullaev, S A Treglazova
Published 2017-07-01

The effects of mutational profiles on phenotypic presentation of myeloproliferative neoplasm subtypes in Bosnia: 18 year follow-up

by Amina Kurtovic-Kozaric, Erna Islamagic, Hana Komic, Nurija Bilalovic, Izet Eminovic, Adnan Burekovic, Amna Uzunovic, Sabira Kurtovic
Published 2019-10-01

Editorial: Novel Treatment Strategies for Myeloproliferative Neoplasms

by Ken-Hong Lim, Ken-Hong Lim, Shinobu Matsuura, Bing Xu, Bing Xu
Published 2021-09-01

CLINICAL AND LABORATORY FEATURES OF ESSENTIAL THROMBOCYTOSIS AND PRIMARY MYELOFIBROSIS DEPENDING ON JAK2 AND CALR1 MUTATION STATUS

by E. G. lisina, N. T. Siordiya, P. A. Butylin, A. A. Silyutina, N. M. Matyukhina, O. M. Senderova, E. S. Fokina, V. A. Ovsepyan, E. G. Lomaia, A. Yu. Zaritskiy
Published 2017-10-01

Cancer Immune Therapy for Philadelphia Chromosome-Negative Chronic Myeloproliferative Neoplasms

by Morten Orebo Holmström, Hans Carl Hasselbalch, Mads Hald Andersen
Published 2020-07-01